Sodium hydride → 2-((3-cyclohexyl-6-(methoxycarbonyl)-2-(2-vinylphenyl)-1H-indol-1-yl)methyl)acrylic acid

HRID 1394838

反応式

HRID 1394838 の反応式
[H-].[Na+].[CH:3]1([C:9]2[C:17]3[C:12](=[CH:13][C:14]([C:18]([O:20][CH3:21])=[O:19])=[CH:15][CH:16]=3)[NH:11][C:10]=2[C:22]2[CH:27]=[CH:26][CH:25]=[CH:24][C:23]=2[CH:28]=[CH2:29])[CH2:8][CH2:7][CH2:6][CH2:5][CH2:4]1.[H][H].Br[CH2:33][C:34](=[CH2:38])[C:35]([OH:37])=[O:36]>C1COCC1.CN(C=O)C>[CH:3]1([C:9]2[C:17]3[C:12](=[CH:13][C:14]([C:18]([O:20][CH3:21])=[O:19])=[CH:15][CH:16]=3)[N:11]([CH2:38][C:34](=[CH2:33])[C:35]([OH:37])=[O:36])[C:10]=2[C:22]2[CH:27]=[CH:26][CH:25]=[CH:24][C:23]=2[CH:28]=[CH2:29])[CH2:8][CH2:7][CH2:6][CH2:5][CH2:4]1

参加物

7

反応物 4

HCID 24758Sodium hydrideHCID 5588842-(Bromomethyl)propenoic acidHCID 58765232methyl 3-cyclohexyl-2-(2-vinylphenyl)1H-indole-6-carboxylateHCID 178418361HCID 178418361、化合物

生成物 1

HCID 692042162-((3-cyclohexyl-6-(methoxycarbonyl)-2-(2-vinylphenyl)-1H-indol-1-yl)methyl)acrylic acid収率 45.9%

試薬・触媒・溶媒 2

HCID 6228Dimethylformamide溶媒HCID 8028Tetrahydrofuran溶媒2 回

実験手順

Sodium hydride (155 mg of a 95% dispersion in mineral oil, 6.13 mmol) was added in portions during 5 min to a stirred and cooled solution (ice-water bath) of 7 (1.0 g, 2.79 mmol) in THF (7 mL). When the evolution of hydrogen subsided DMF (2 mL) was added followed by a solution of bromomethylacrylic acid (505 mg, 3.06 mmol) in THF (1.5 mL). Stirring was continued with cooling (10 min) and then at 22° C. for 30 min. The mixture was concentrated and the residue partitioned between ethyl acetate and water. The organic layer was washed (water, brine), dried (sodium sulfate) and concentrated. The residue was chromatographed on silicic acid (15 g) using the flash technique and eluting with methylene chloride:ethyl acetate:acetic acid (10:1:0.005). The product containing fraction was concentrated on a rotary evaporator to leave 2-((3-cyclohexyl-6-(methoxycarbonyl)-2-(2-vinylphenyl)-1H-indol-1-yl)methyl)acrylic acid (568 mg, 40%) as a yellow gum. A sample (142 mg) was further purified on a Shimadzu preparatory liquid chromatograph. The fraction containing the product was concentrated to leave 13 (R=H) as a granular solid. ESI-MS m/z 433 (MH+), 1H NMR (500 MHz, CHLOROFORM-D) δ ppm 1.07-1.37 (m, 3H) 1.58-1.88 (m, 7 H) 2.41-2.53 (m, 1 H) 3.93 (s, 3 H) 4.50 (d, J=18.31 Hz, 1 H) 4.84 (d, J=18.31 Hz, 1 H) 4.89 (s, 1 H) 5.13 (d, J=10.99 Hz, 1 H) 5.29 (s, 1 H) 5.68 (d, J=17.70 Hz, 1 H) 6.19 (s, 1 H) 6.36 (dd, J=17.55, 11.14 Hz, 1 H) 7.15 (d, J=7.63 Hz, 1 H) 7.31 (t, J=7.48 Hz, 1 H) 7.45 (t, J=7.63 Hz, 1 H) 7.70 (d, J=7.93 Hz, 1 H) 7.76-7.87 (m, 2H) 7.96 (s, 1 H).

後処理

  1. additionwas added
  2. stirringStirring
  3. temperaturewith cooling (10 min)
  4. concentrationThe mixture was concentrated
  5. customthe residue partitioned between ethyl acetate and water
  6. washThe organic layer was washed (water, brine)
  7. dry with materialdried (sodium sulfate)
  8. concentrationconcentrated
  9. customThe residue was chromatographed on silicic acid (15 g)
  10. washeluting with methylene chloride:ethyl acetate:acetic acid (10:1:0.005)
  11. additionThe product containing fraction
  12. concentrationwas concentrated on a rotary evaporator

出典と根拠

ORDレコード
ord-6f14a411c5ce4506b93d00daf87693c8
出典データセット
uspto-grants-2008_03
特許番号
US07348425B2

関連ノート

読み込み中…